T1	Pharmacodynamic_phenotype	75 96	response to therapy ,
T2	Gene_or_protein	114 124	SLC6A4 and
T3	Pharmacodynamic_phenotype	125 172	responses to the 5-HT3 antagonist alosetron and
T4	Pharmacodynamic_phenotype	173 204	the 5-HT4 agonist , tegaserod .
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	influences	Arg1:T1	Arg2:T4
R4	influences	Arg1:T2	Arg2:T1
R5	influences	Arg1:T2	Arg2:T3
R6	influences	Arg1:T2	Arg2:T4
R7	influences	Arg1:T3	Arg2:T1
R8	isAssociatedWith	Arg1:T3	Arg2:T2
R9	influences	Arg1:T3	Arg2:T4
R10	influences	Arg1:T4	Arg2:T1
R11	treats	Arg1:T4	Arg2:T2
R12	influences	Arg1:T4	Arg2:T3
